Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

T2 Biosystems CS (TTOO)

T2 Biosystems CS (TTOO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

T2 Biosystems CS 101 HARTWELL AVENUE LEXINGTON MA 02421 USA

P: 781-761-4646 F: 781-357-3080

Description:

T2 Biosystems, Inc. is an in vitro diagnostics company. It has developed a technology platform that is designed to offer a rapid, sensitive and simple alternative to existing diagnostic methodologies. The Company uses its T2 Magnetic Resonance platform, or T2MR, that enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets. It operates primarily in the United States. T2 Biosystems, Inc. is headquartered in Lexington, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 27,195
Shares Outstanding, K 171,037
Annual Sales, $ 28,060 K
Annual Net Income, $ -49,240 K
Last Quarter Sales, $ 7,230 K
Last Quarter Net Income, $ -16,500 K
60-Month Beta 0.63
% of Insider Shareholders 6.90%
% of Institutional Shareholders 11.23%
Float, K 159,235
% Float 93.10%
Short Volume Ratio 0.47

Growth:

1-Year Return -85.41%
3-Year Return -89.40%
5-Year Return -94.00%
5-Year Revenue Growth 587.75%
5-Year Earnings Growth 85.24%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.10 on 05/05/22
Next Earnings Date 08/04/22
Earnings Per Share ttm -0.33
EPS Growth vs. Prev Qtr -42.86%
EPS Growth vs. Prev Year -42.86%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

TTOO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -85.22%
Profit Margin % -175.48
Net Margin % N/A
Debt/Equity N/A
Price/Sales 1.15
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.15
Interest Coverage -6.47
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar